The Mesothelioma Guide Blog

Encouraging results from a clinical trial at MD Anderson Cancer Center raised an important question. After approval for pleural mesothelioma, can two immunotherapy drugs work for...

A California jury ruled in favor of a 35‑year‑old mesothelioma victim against Johnson & Johnson, the manufacturer at the center of thousands of lawsuits. Johnson &...

Do the chemotherapy drugs used during HIPEC matter for survival? That’s the basis of a new clinical trial at the National Cancer Institute. Researchers are looking into whether...

Hot chemotherapy seems to supplement radical surgery quite well, especially for peritoneal mesothelioma. For pleural mesothelioma, the feelings are divided. Numerous reports...

Peritoneal mesothelioma, a cancer of the abdominal lining, often deceives doctors, patients and more of its presence. The main reason for this is the signs of peritoneal...

Opdivo and Yervoy are helping people with pleural mesothelioma live longer. Could the same happen for people with peritoneal mesothelioma? The U.S. Food and Drug Administration...

Using checkpoint inhibitors is the latest hot‑button topic among oncologists and cancer specialists. Mesothelioma is no different. Most use immune checkpoint inhibitors, a form...

With bankruptcy in mind, Johnson & Johnson took another big shot in its fight against mesothelioma claims. According to a report from Bloomberg Law, a California appellate...

Is the internet trustworthy? That’s a loaded question, one without a clear‑cut answer. Zoom in a little closer: Is the internet trustworthy for researching cancer? It’s a...

The top mesothelioma cancer centers in the world offer experienced staff, plenty of treatment options and additional support resources. There’s a subset within the segment of...